Septerna, Inc.(SEPN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SEPN Septerna, Inc.

盘前交易 07-30 06:29:54 EDT

12.75

-1.08

-7.81%

最高13.29	最低12.25	成交量32.99万
今开13.29	昨收13.83	日振幅7.52%
总市值5.68亿	流通市值2.32亿	总股本4,456万
成交额423.26万	换手率1.81%	流通股本1,818万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"SEPN","market":"US","secType":"STK","nameCN":"Septerna, Inc.","latestPrice":12.75,"timestamp":1753819200000,"preClose":13.83,"halted":0,"volume":329871,"delay":0,"floatShares":18175938,"shares":44558338,"eps":-3.894174,"marketStatus":"盘前交易","change":-1.08,"latestTime":"07-30 06:29:54 EDT","open":13.29,"high":13.29,"low":12.25,"amount":4232600.201067001,"amplitude":0.075199,"askPrice":14.65,"askSize":100,"bidPrice":12.6,"bidSize":20,"shortable":0,"etf":0,"ttmEps":-3.894174,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753882200000},"marketStatusCode":1,"adr":0,"listingDate":1729828800000,"exchange":"NASDAQ","adjPreClose":12.75,"postHourTrading":{"tag":"盘后","latestPrice":12.75,"preClose":12.75,"latestTime":"19:59 EDT","volume":118,"amount":1503.3396,"timestamp":1753833596202},"volumeRatio":1.6192719671536024,"impliedVol":0.578,"impliedVolPercentile":0.2174},"requestUrl":"/m/hq/s/SEPN","defaultTab":"news","newsList":[{"id":"2545416238","title":"Septerna(SEPN.US)获HC Wainwright & Co.首次覆盖，给予买入评级, 目标价26.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545416238","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545416238?lang=zh_cn&edition=full","pubTime":"2025-06-23 19:24","pubTimestamp":1750677898,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4007","SEPN"],"gpt_icon":0},{"id":"2542056932","title":"Septerna, Inc.6月11日成交额为509.90万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542056932","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542056932?lang=zh_cn&edition=full","pubTime":"2025-06-12 12:51","pubTimestamp":1749703908,"startTime":"0","endTime":"0","summary":"美东时间2025年6月11日，Septerna, Inc.成交额为509.90万美元，成交额较昨日增加6.75%，当日成交量为49.85万股。Septerna, Inc.于2025年6月11日涨0.0%，报10.28美元，该股过去5个交易日涨3.11%，年初至今跌55.11%，过去60日涨62.15%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-11|509.90万|6.75%|49.85万|#|2025-06-10|477.67万|23.34%|46.94万|#|2025-06-09|387.27万|-55.50%|38.26万|#|2025-06-06|870.29万|-16.47%|84.22万|#|2025-06-05|1041.90万|136.32%|100.31万|Septerna Inc 是一家临床阶段的生物技术公司，开创了G蛋白偶联受体口服小分子药物发现的新时代，该公司拥有专有的天然复合物平台。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612125149a4a46ea2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612125149a4a46ea2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SEPN","BK4007"],"gpt_icon":0},{"id":"2542379513","title":"Septerna, Inc.6月10日成交额为477.67万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542379513","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542379513?lang=zh_cn&edition=full","pubTime":"2025-06-11 12:29","pubTimestamp":1749616176,"startTime":"0","endTime":"0","summary":"美东时间2025年6月10日，Septerna, Inc.成交额为477.67万美元，成交额较昨日增加23.34%，当日成交量为46.94万股。Septerna, Inc.于2025年6月10日涨1.68%，报10.28美元，该股过去5个交易日涨3.11%，年初至今跌55.11%，过去60日涨63.17%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-10|477.67万|23.34%|46.94万|#|2025-06-09|387.27万|-55.50%|38.26万|#|2025-06-06|870.29万|-16.47%|84.22万|#|2025-06-05|1041.90万|136.32%|100.31万|#|2025-06-04|440.88万|44.57%|43.77万|Septerna Inc 是一家临床阶段的生物技术公司，开创了G蛋白偶联受体口服小分子药物发现的新时代，该公司拥有专有的天然复合物平台。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611122937a4a2e88c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611122937a4a2e88c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SEPN","BK4007"],"gpt_icon":0},{"id":"2542190366","title":"Septerna, Inc.6月9日成交额为387.27万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542190366","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542190366?lang=zh_cn&edition=full","pubTime":"2025-06-10 12:19","pubTimestamp":1749529166,"startTime":"0","endTime":"0","summary":"美东时间2025年6月9日，Septerna, Inc.成交额为387.27万美元，成交额较昨日减少55.50%，当日成交量为38.26万股。Septerna, Inc.于2025年6月9日跌0.98%，报10.11美元，该股过去5个交易日涨1.81%，年初至今跌55.85%，过去60日涨58.22%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-09|387.27万|-55.50%|38.26万|#|2025-06-06|870.29万|-16.47%|84.22万|#|2025-06-05|1041.90万|136.32%|100.31万|#|2025-06-04|440.88万|44.57%|43.77万|#|2025-06-03|304.97万|-50.66%|30.69万|Septerna Inc 是一家临床阶段的生物技术公司，开创了G蛋白偶联受体口服小分子药物发现的新时代，该公司拥有专有的天然复合物平台。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610121938a7018ca3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610121938a7018ca3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SEPN","BK4007"],"gpt_icon":0},{"id":"2541882846","title":"Septerna, Inc.6月5日成交额为1041.90万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2541882846","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541882846?lang=zh_cn&edition=full","pubTime":"2025-06-06 12:35","pubTimestamp":1749184530,"startTime":"0","endTime":"0","summary":"美东时间2025年6月5日，Septerna, Inc.成交额为1041.90万美元，成交额较昨日增加136.32%，当日成交量为100.31万股。Septerna, Inc.于2025年6月5日涨5.52%，报10.52美元，该股过去5个交易日涨6.69%，年初至今跌54.06%，过去60日涨57.49%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-05|1041.90万|136.32%|100.31万|#|2025-06-04|440.88万|44.57%|43.77万|#|2025-06-03|304.97万|-50.66%|30.69万|#|2025-06-02|618.10万|-17.09%|62.75万|#|2025-05-30|745.52万|74.72%|79.64万|Septerna Inc 是一家临床阶段的生物技术公司，开创了G蛋白偶联受体口服小分子药物发现的新时代，该公司拥有专有的天然复合物平台。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606123535a49c5bcc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606123535a49c5bcc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SEPN","BK4007"],"gpt_icon":0},{"id":"2540769038","title":"Septerna, Inc.6月3日成交额为304.97万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2540769038","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540769038?lang=zh_cn&edition=full","pubTime":"2025-06-04 12:27","pubTimestamp":1749011261,"startTime":"0","endTime":"0","summary":"美东时间2025年6月3日，Septerna, Inc.成交额为304.97万美元，成交额较昨日减少50.66%，当日成交量为30.69万股。Septerna, Inc.于2025年6月3日涨0.4%，报9.97美元，该股过去5个交易日涨3.32%，年初至今跌56.46%，过去60日涨55.05%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-03|304.97万|-50.66%|30.69万|#|2025-06-02|618.10万|-17.09%|62.75万|#|2025-05-30|745.52万|74.72%|79.64万|#|2025-05-29|426.70万|17.76%|43.15万|#|2025-05-28|362.34万|-56.96%|37.27万|Septerna Inc 是一家临床阶段的生物技术公司，开创了G蛋白偶联受体口服小分子药物发现的新时代，该公司拥有专有的天然复合物平台。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250604122751a6f9a2dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250604122751a6f9a2dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SEPN","BK4007"],"gpt_icon":0},{"id":"2540749590","title":"Septerna, Inc.6月2日成交额为618.10万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2540749590","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540749590?lang=zh_cn&edition=full","pubTime":"2025-06-03 12:20","pubTimestamp":1748924451,"startTime":"0","endTime":"0","summary":"美东时间2025年6月2日，Septerna, Inc.成交额为618.10万美元，成交额较昨日减少17.09%，当日成交量为62.75万股。Septerna, Inc.于2025年6月2日涨7.35%，报9.93美元，该股过去5个交易日涨8.05%，年初至今跌56.64%，过去60日涨56.13%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-02|618.10万|-17.09%|62.75万|#|2025-05-30|745.52万|74.72%|79.64万|#|2025-05-29|426.70万|17.76%|43.15万|#|2025-05-28|362.34万|-56.96%|37.27万|#|2025-05-27|841.91万|143.52%|87.40万|Septerna Inc 是一家临床阶段的生物技术公司，开创了G蛋白偶联受体口服小分子药物发现的新时代，该公司拥有专有的天然复合物平台。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603122057a497a1aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603122057a497a1aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SEPN","BK4007"],"gpt_icon":0},{"id":"2539214947","title":"Septerna, Inc.5月29日成交额为426.70万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2539214947","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539214947?lang=zh_cn&edition=full","pubTime":"2025-05-30 12:19","pubTimestamp":1748578778,"startTime":"0","endTime":"0","summary":"美东时间2025年5月29日，Septerna, Inc.成交额为426.70万美元，成交额较昨日增加17.76%，当日成交量为43.15万股。Septerna, Inc.于2025年5月29日涨1.44%，报9.86美元，该股过去5个交易日涨8.83%，年初至今跌56.94%，过去60日涨60.06%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-05-29|426.70万|17.76%|43.15万|#|2025-05-28|362.34万|-56.96%|37.27万|#|2025-05-27|841.91万|143.52%|87.40万|#|2025-05-23|345.72万|-47.80%|37.32万|#|2025-05-22|662.31万|2.48%|70.17万|Septerna Inc 是一家临床阶段的生物技术公司，开创了G蛋白偶联受体口服小分子药物发现的新时代，该公司拥有专有的天然复合物平台。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530121947a6f2b8d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530121947a6f2b8d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SEPN","BK4007"],"gpt_icon":0},{"id":"2537153744","title":"Septerna, Inc.2025财年第一财季实现净利润-21.48百万美元，同比减少51.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537153744","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537153744?lang=zh_cn&edition=full","pubTime":"2025-05-24 00:01","pubTimestamp":1748016060,"startTime":"0","endTime":"0","summary":"5月24日，Septerna, Inc.公布财报，公告显示公司2025财年第一财季净利润为-21.48百万美元，同比减少51.59%；其中营业收入为219000.00美元，同比减少30.91%，每股基本收益为-0.49美元。从资产负债表来看，Septerna, Inc.总负债33.75百万美元，其中短期债务1.94百万美元，资产负债比为0.13，流动比率为0.33。机构评级：截至2025年5月24日，当前有3家机构对Septerna, Inc.目标价做出预测，其中目标均价为23.67美元，其中最低目标价为18.00美元，最高目标价为28.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250524000141a6ea7d3e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250524000141a6ea7d3e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SEPN"],"gpt_icon":0},{"id":"2536665722","title":"Septerna, Inc.5月19日成交额为1067.40万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536665722","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536665722?lang=zh_cn&edition=full","pubTime":"2025-05-20 11:30","pubTimestamp":1747711837,"startTime":"0","endTime":"0","summary":"美东时间2025年5月19日，Septerna, Inc.成交额为1067.40万美元，成交额较昨日减少54.13%，当日成交量为107.99万股。Septerna, Inc.于2025年5月19日涨1.32%，报9.97美元，该股过去5个交易日涨42.84%，年初至今跌56.46%，过去60日涨71.9%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-05-19|1067.40万|-54.13%|107.99万|#|2025-05-16|2326.87万|-29.53%|233.42万|#|2025-05-15|3301.74万|-91.26%|336.04万|#|2025-05-14|3.78亿|24652.34%|3781.58万|#|2025-05-13|152.53万|0.72%|22.79万|Septerna Inc 是一家临床阶段的生物技术公司，开创了G蛋白偶联受体口服小分子药物发现的新时代，该公司拥有专有的天然复合物平台。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520113046a484d32d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520113046a484d32d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","SEPN"],"gpt_icon":0},{"id":"2536372954","title":"诺和诺德豪掷2亿美元，押注口服减重小分子，与Septerna共拓多靶点代谢新药版图","url":"https://stock-news.laohu8.com/highlight/detail?id=2536372954","media":"动脉网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536372954?lang=zh_cn&edition=full","pubTime":"2025-05-17 12:13","pubTimestamp":1747455180,"startTime":"0","endTime":"0","summary":"诺和诺德与Septerna达成合作协议，以2亿美元预付款获取口服小分子药物全球开发与商业化权利，意在与礼来在口服代谢药物市场上竞争，这些药物可靶向GLP-1、GIP和胰高血糖素等热门靶点，标志着诺和诺德在口服多靶点疗法方向的战略前移。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051712152194f99edb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051712152194f99edb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SEPN","LU0154236417.USD","NVO","BK4585","BK4599","LU1093756325.SGD","LU1093756168.USD","BK4532","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","BK4588","BK4007"],"gpt_icon":0},{"id":"2535137223","title":"富国银行：维持Septerna(SEPN.US)评级，由持股观望调整至持股观望评级, 目标价由11.00美元调整至18.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2535137223","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535137223?lang=zh_cn&edition=full","pubTime":"2025-05-16 21:44","pubTimestamp":1747403093,"startTime":"0","endTime":"0","summary":"富国银行：维持Septerna(SEPN.US)评级，由持股观望调整至持股观望评级, 目标价由11.00美元调整至18.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/16214450462951.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["SEPN"],"gpt_icon":0},{"id":"2535335605","title":"Septerna, Inc.5月15日成交额为3301.74万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535335605","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535335605?lang=zh_cn&edition=full","pubTime":"2025-05-16 11:28","pubTimestamp":1747366108,"startTime":"0","endTime":"0","summary":"美东时间2025年5月15日，Septerna, Inc.成交额为3301.74万美元，成交额较昨日减少91.26%，当日成交量为336.04万股。Septerna, Inc.于2025年5月15日跌0.39%，报10.12美元，该股过去5个交易日涨45.61%，年初至今跌55.81%，过去60日涨82.34%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-05-15|3301.74万|-91.26%|336.04万|#|2025-05-14|3.78亿|24652.34%|3781.58万|#|2025-05-13|152.53万|0.72%|22.79万|#|2025-05-12|151.44万|35.65%|21.75万|#|2025-05-09|111.64万|-34.57%|16.48万|Septerna Inc 是一家临床阶段的生物技术公司，开创了G蛋白偶联受体口服小分子药物发现的新时代，该公司拥有专有的天然复合物平台。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516112834a4805bb3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516112834a4805bb3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SEPN","BK4007"],"gpt_icon":0},{"id":"2535185937","title":"Septerna, Inc.5月14日成交额为3.78亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535185937","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535185937?lang=zh_cn&edition=full","pubTime":"2025-05-15 11:20","pubTimestamp":1747279245,"startTime":"0","endTime":"0","summary":"美东时间2025年5月14日，Septerna, Inc.成交额为3.78亿美元，成交额较昨日增加24652.34%，当日成交量为3781.58万股。Septerna, Inc.于2025年5月14日涨50.97%，报10.16美元，该股过去5个交易日涨44.11%，年初至今跌55.63%，过去60日涨47.89%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-05-14|3.78亿|24652.34%|3781.58万|#|2025-05-13|152.53万|0.72%|22.79万|#|2025-05-12|151.44万|35.65%|21.75万|#|2025-05-09|111.64万|-34.57%|16.48万|#|2025-05-08|170.61万|38.07%|24.31万|Septerna Inc 是一家临床阶段的生物技术公司，开创了G蛋白偶联受体口服小分子药物发现的新时代，该公司拥有专有的天然复合物平台。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515112053a6dfc529&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515112053a6dfc529&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SEPN","BK4007"],"gpt_icon":0},{"id":"2535782700","title":"Macrogenics, Inc.盘中异动 早盘快速拉升5.19%报1.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535782700","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535782700?lang=zh_cn&edition=full","pubTime":"2025-05-14 21:45","pubTimestamp":1747230305,"startTime":"0","endTime":"0","summary":"北京时间2025年05月14日21时45分，Macrogenics, Inc.股票出现波动，股价快速上涨5.19%。截至发稿，该股报1.62美元/股，成交量6.3556万股，换手率0.10%，振幅5.84%。Macrogenics, Inc.股票所在的生物技术行业中，整体涨幅为0.13%。Macrogenics, Inc.公司简介：Macrogenics Inc是一家生物技术公司，专注于发现和开发用于治疗癌症的基于抗体的疗法。它的产品包括MARGENZA，用于治疗患有转移性HER2阳性乳腺癌的成年患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051421450694f6ca59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051421450694f6ca59&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MGNX","BK4007","SEPN","BK4139"],"gpt_icon":0},{"id":"2535765150","title":"Cardio Diagnostics Holdings Inc C/Wts (10/25/2027) To Pur Com股价拉升42.24% 市值涨308.23万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535765150","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535765150?lang=zh_cn&edition=full","pubTime":"2025-05-14 21:44","pubTimestamp":1747230241,"startTime":"0","endTime":"0","summary":"北京时间2025年05月14日21时44分，Cardio Diagnostics Holdings Inc C/Wts  To Pur Com股票出现异动，股价急速拉升42.24%。Cardio Diagnostics Holdings Inc C/Wts  To Pur Com股票所在的生物技术行业中，整体涨幅为0.10%。Cardio Diagnostics Holdings Inc C/Wts  To Pur Com公司简介：Cardio Diagnostics Holdings Inc 是一家医疗技术公司，专注在开发和商业化基于表观遗传学的心血管疾病临床测试。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514214401a47e4136&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514214401a47e4136&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CDIOW","BK4007","SEPN"],"gpt_icon":0},{"id":"2535020515","title":"Palisade Bio, Inc.盘中异动 早盘股价大跌5.49%报0.690美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535020515","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535020515?lang=zh_cn&edition=full","pubTime":"2025-05-14 21:43","pubTimestamp":1747230208,"startTime":"0","endTime":"0","summary":"北京时间2025年05月14日21时43分，Palisade Bio, Inc.股票出现异动，股价急速下挫5.49%。截至发稿，该股报0.690美元/股，成交量5.8924万股，换手率1.28%，振幅4.78%。Palisade Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。Palisade Bio, Inc.公司简介：Palisade Bio Inc 是一家临床阶段的生物制药公司，专注于识别和开发保护肠道屏障完整性的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514214328a6df0af5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514214328a6df0af5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SEPN","BK4007","BK4139","PALI"],"gpt_icon":0},{"id":"2535707379","title":"Engene Holdings Inc.盘中异动 急速下挫5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535707379","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535707379?lang=zh_cn&edition=full","pubTime":"2025-05-14 21:42","pubTimestamp":1747230168,"startTime":"0","endTime":"0","summary":"北京时间2025年05月14日21时42分，Engene Holdings Inc.股票出现异动，股价快速下挫5.21%。截至发稿，该股报2.73美元/股，成交量4.8025万股，换手率0.09%，振幅3.13%。Engene Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.22%。Engene Holdings Inc.公司简介：enGene Holdings Inc .是一家临床阶段的生物技术公司，致力于开发基因疗法以改善患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514214248a47e40cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514214248a47e40cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ENGN","SEPN","BK4007"],"gpt_icon":0},{"id":"2535208030","title":"Abcellera Biologics Inc.盘中异动 大幅拉升5.24%报2.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535208030","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535208030?lang=zh_cn&edition=full","pubTime":"2025-05-14 21:41","pubTimestamp":1747230061,"startTime":"0","endTime":"0","summary":"北京时间2025年05月14日21时41分，Abcellera Biologics Inc.股票出现异动，股价大幅上涨5.24%。截至发稿，该股报2.21美元/股，成交量33.3572万股，换手率0.11%，振幅4.76%。Abcellera Biologics Inc.股票所在的生物技术行业中，整体涨幅为0.30%。Abcellera Biologics Inc.公司简介：AbCellera Biologics Inc 是一家专门设计用于克服传统发现障碍的抗体发现和开发引擎，能够以更高的精确度和速度找到最佳临床候选药物，更快地用于临床和患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514214102a47e4050&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514214102a47e4050&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABCL","BK4535","BK4121","BK4007","SEPN"],"gpt_icon":0},{"id":"2535205470","title":"Inflarx N.V.盘中异动 股价大涨5.03%报1.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535205470","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535205470?lang=zh_cn&edition=full","pubTime":"2025-05-14 21:40","pubTimestamp":1747230023,"startTime":"0","endTime":"0","summary":"北京时间2025年05月14日21时40分，Inflarx N.V.股票出现波动，股价急速上涨5.03%。截至发稿，该股报1.88美元/股，成交量1.6301万股，换手率0.02%，振幅4.53%。Inflarx N.V.股票所在的生物技术行业中，整体涨幅为0.26%。其相关个股中，Septerna, Inc.、蓝鸟生物、Quoin Pharmaceuticals Ltd涨幅较大，Nucana Plc、Polyrizon Ltd.、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为2278.34%、1544.95%、1272.44%，振幅较大的相关个股有Humacyte Inc C/Wts 27/08/2026 、Septerna, Inc.、Nucana Plc，振幅分别为46.33%、26.75%、23.40%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514214024a6df0a5c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514214024a6df0a5c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SEPN","BK4139","BK4007","IFRX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.septerna.com","stockEarnings":[{"period":"1week","weight":0.0225},{"period":"1month","weight":0.2131},{"period":"3month","weight":0.8319},{"period":"6month","weight":-0.2801},{"period":"1year","weight":-0.2917},{"period":"ytd","weight":-0.4432}],"compareEarnings":[{"period":"1week","weight":0.0102},{"period":"1month","weight":0.0331},{"period":"3month","weight":0.1456},{"period":"6month","weight":0.0499},{"period":"1year","weight":0.1661},{"period":"ytd","weight":0.0839}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Septerna, Inc.于2019年12月在特拉华州注册成立，名称为GPCR NewCo, Inc.。2021年6月，他们更名为Septerna, Inc.。该公司是一家临床阶段的生物技术公司，开创了G蛋白偶联受体（GPCR）口服小分子药物发现的新时代，其动力来自其专有的Native Complex PlatformTM。他们的工业规模平台旨在释放GPCR疗法的全部潜力，并发现和开发其深度候选产品管道，最初专注于治疗三个治疗领域的患者：内分泌学、免疫学和炎症，以及代谢疾病。","exchange":"NASDAQ","name":"Septerna, Inc.","nameEN":"Septerna, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Septerna, Inc.(SEPN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Septerna, Inc.(SEPN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Septerna, Inc.,SEPN,Septerna, Inc.股票,Septerna, Inc.股票老虎,Septerna, Inc.股票老虎国际,Septerna, Inc.行情,Septerna, Inc.股票行情,Septerna, Inc.股价,Septerna, Inc.股市,Septerna, Inc.股票价格,Septerna, Inc.股票交易,Septerna, Inc.股票购买,Septerna, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Septerna, Inc.(SEPN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Septerna, Inc.(SEPN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}